| |
| |
|
| Insider
Information: |
Han Queena |
| Relationship: |
VP Finance & HR |
| City: |
Austin |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
57,692 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$454,036 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
57,692 |
|
|
| Total
Value |
$454,036 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -23.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
xBiotech Inc |
XBIT |
VP Finance & HR |
2020-09-01 |
57,692 |
2015-12-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XBIT |
xBiotech Inc |
VP Finance & HR |
• – – |
2020-09-01 |
4 |
OE |
$4.16 |
$242,399 |
D/D |
57,692 |
57,692 |
0 |
- |
|
| XBIT |
xBiotech Inc |
VP Finance & HR |
• – – |
2020-08-24 |
4 |
S |
$19.65 |
$1,018,899 |
D/D |
(51,841) |
0 |
0 |
% |
|
| XBIT |
xBiotech Inc |
VP Finance & HR |
• – – |
2020-08-24 |
4 |
OE |
$4.14 |
$346,000 |
D/D |
51,841 |
12,500 |
0 |
- |
|
| XBIT |
xBiotech Inc |
VP Finance & HR |
• – – |
2020-08-17 |
4 |
S |
$19.30 |
$25,090 |
D/D |
(1,300) |
0 |
0 |
% |
|
| XBIT |
xBiotech Inc |
VP Finance & HR |
• – – |
2020-08-17 |
4 |
OE |
$7.50 |
$9,750 |
D/D |
1,300 |
1,300 |
0 |
- |
|
| XBIT |
xBiotech Inc |
VP Finance & HR |
• – – |
2018-03-23 |
4 |
OE |
$2.50 |
$20,503 |
D/D |
8,201 |
8,201 |
0 |
- |
|
| XBIT |
xBiotech Inc |
VP Finance & HR |
• – – |
2018-03-23 |
4 |
S |
$4.75 |
$38,955 |
D/D |
(8,201) |
0 |
0 |
- |
|
| XBIT |
xBiotech Inc |
VP Finance & HR |
• – – |
2018-03-22 |
4 |
S |
$4.76 |
$296,159 |
D/D |
(62,200) |
0 |
0 |
- |
|
| XBIT |
xBiotech Inc |
VP Finance & HR |
• – – |
2018-03-22 |
4 |
OE |
$2.50 |
$155,500 |
D/D |
62,200 |
62,200 |
0 |
- |
|
| XBIT |
xBiotech Inc |
VP Finance & HR |
• – – |
2018-03-21 |
4 |
S |
$4.48 |
$42,987 |
D/D |
(9,599) |
0 |
0 |
- |
|
| XBIT |
xBiotech Inc |
VP Finance & HR |
• – – |
2018-03-21 |
4 |
OE |
$2.50 |
$23,998 |
D/D |
9,599 |
9,599 |
0 |
- |
|
| XBIT |
xBiotech Inc |
VP Finance & HR |
• – – |
2016-11-15 |
4 |
S |
$15.00 |
$293,595 |
D/D |
(19,573) |
0 |
0 |
- |
|
| XBIT |
xBiotech Inc |
VP Finance & HR |
• – – |
2016-11-15 |
4 |
OE |
$0.74 |
$14,484 |
D/D |
19,573 |
19,573 |
0 |
- |
|
| XBIT |
xBiotech Inc |
VP Finance & HR |
• – – |
2016-09-08 |
4 |
S |
$15.00 |
$6,405 |
D/D |
(427) |
0 |
0 |
- |
|
| XBIT |
xBiotech Inc |
VP Finance & HR |
• – – |
2016-09-08 |
4 |
OE |
$0.77 |
$329 |
D/D |
427 |
427 |
0 |
- |
|
| XBIT |
xBiotech Inc |
VP Finance / HR |
• – – |
2015-12-22 |
4 |
OE |
$0.72 |
$7,200 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| XBIT |
xBiotech Inc |
VP Finance / HR |
• – – |
2015-12-22 |
4 |
S |
$10.27 |
$102,743 |
D/D |
(10,000) |
0 |
0 |
- |
|
| XBIT |
xBiotech Inc |
VP Finance / HR |
• – – |
2015-12-21 |
4 |
S |
$10.11 |
$102,616 |
D/D |
(10,000) |
0 |
0 |
- |
|
| XBIT |
xBiotech Inc |
VP Finance / HR |
• – – |
2015-12-21 |
4 |
OE |
$0.72 |
$7,200 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| XBIT |
xBiotech Inc |
VP Finance / HR |
• – – |
2015-12-18 |
4 |
S |
$10.51 |
$106,354 |
D/D |
(10,000) |
0 |
0 |
- |
|
| XBIT |
xBiotech Inc |
VP Finance / HR |
• – – |
2015-12-18 |
4 |
OE |
$0.72 |
$7,200 |
D/D |
10,000 |
10,000 |
0 |
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
